跳至主要内容
临床试验/NCT05920824
NCT05920824招募中不适用

Clinical Phenotypes, Risk Factors, & Determinants of Outcome in Functional Mitral and Tricuspid Valve Regurgitation

Barts & The London NHS Trust1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2023年8月23日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
60
试验地点
1
主要终点
Effective Regurgitant Orifice Area at 1 year

研究概览

简要总结

A prospective, observational cohort study designed to identify clinical phenotypes and evaluate predictors & outcomes of functional mitral and tricuspid valve regurgitation in patients with atrial fibrillation.

Participant will under go:

  • Baseline echocardiography
  • Cpex Echocardiography
  • Blood test: BNP
  • 1 year follow up Echocardiography

Participants will be stratified into three subgroups:

  • Atrial Functional MR
  • Atrial Functional TR
  • Mixed MR & TR

详细描述

Rationale

The natural history and risk factors for atrial valve disease are poorly understood and characterised. This study will examine differences between atrial mitral and atrial tricuspid disease and help us understand the natural history of these pathologies.

Study objectives

Primary objective

  • Identify & characterise phenotypes in functional mitral and tricuspid valve regurgitation
  • Identify risk factors for progression of disease and outcome.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Informed consent
  • Age of 18 years or older
  • Atrial fibrillation
  • Moderate or severe atrial valve disease
  • Adequate 2D echocardiography views including parasternal long axis, short axis, apical two chamber, apical three chamber and four chamber.

排除标准

  • Unwilling or unable to give consent
  • Left ventricular impairment (ejection fraction < 50%).
  • Primary/organic valve disease

结局指标

主要结局

Effective Regurgitant Orifice Area at 1 year

时间窗: 1 year

Measure the EROA by echocardiography after 1 year

次要结局

  • Heart Failure admission within 1 year of recruitment.(1 year)
  • Mortality(1 year)
  • Functional: New York Heart Association Class, Predicted VO2max (<84%).(1 year)
  • Progression of valve disease defined as worsening of mitral or tricuspid regurgitation > 1 grade at 1 year.(1 year)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Atrial Functional Mitral Regurgitation and Tricuspid... | 临床试验